Laura Chico
Stock Analyst at Wedbush
(4.71)
# 759
Out of 5,023 analysts
645
Total ratings
49.6%
Success rate
12.1%
Average return
Main Sectors:
Stocks Rated by Laura Chico
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EWTX Edgewise Therapeutics | Reiterated: Buy | $52 → $53 | $41.40 | +28.02% | 24 | Sep 23, 2026 | |
| MAZE Maze Therapeutics | Reiterated: Buy | $48 | $26.43 | +81.61% | 8 | Sep 23, 2026 | |
| TVTX Travere Therapeutics | Reiterated: Buy | $75 → $76 | $56.93 | +33.50% | 36 | Sep 22, 2026 | |
| RARE Ultragenyx Pharmaceutical | Reiterated: Hold | $23 | $15.22 | +51.12% | 58 | Sep 18, 2026 | |
| XENE Xenon Pharmaceuticals | Reiterated: Buy | $63 → $55 | $38.02 | +44.66% | 20 | Sep 18, 2026 | |
| VERA Vera Therapeutics | Reiterated: Hold | $34 | $30.42 | +11.77% | 14 | Sep 16, 2026 | |
| SION Sionna Therapeutics | Reiterated: Hold | $5 → $6 | $4.91 | +22.20% | 5 | Sep 15, 2026 | |
| PHVS Pharvaris | Reiterated: Buy | $42 → $50 | $31.19 | +60.31% | 9 | Sep 9, 2026 | |
| CLYM Climb Bio | Reiterated: Buy | $20 | $10.94 | +82.82% | 7 | Aug 19, 2026 | |
| ARDX Ardelyx | Reiterated: Buy | $19 → $9 | $3.34 | +169.46% | 21 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $80 | $10.71 | +646.97% | 8 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $2.38 | +194.12% | 13 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $14.12 | +232.86% | 12 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $20 | $8.17 | +144.80% | 17 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $43 → $41 | $19.40 | +111.34% | 74 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $105 → $122 | $88.21 | +38.31% | 16 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $11 | $2.96 | +271.62% | 9 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $185 → $194 | $143.18 | +35.49% | 25 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $201 → $215 | $219.88 | -2.22% | 69 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 → $26 | $20.00 | +30.00% | 27 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $166 → $162 | $295.51 | -45.18% | 24 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $16 | $6.85 | +133.58% | 8 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $21 → $24 | $24.80 | -3.23% | 10 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $4 | $2.28 | +75.44% | 13 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 | $25.62 | +48.32% | 15 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $15.25 | +162.30% | 2 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $7 | $2.45 | n/a | 10 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $11 | $17.11 | n/a | 4 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $12.34 | n/a | 8 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $5 | $4.63 | n/a | 5 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $4.13 | n/a | 4 | Feb 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $45 | $0.8112 | n/a | 5 | Aug 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $57.18 | n/a | 15 | Jan 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $504.73 | n/a | 16 | Jan 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $7.96 | n/a | 10 | Sep 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.54 | n/a | 4 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $735.20 | n/a | 16 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $24 | $6.13 | n/a | 1 | Jan 18, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.1964 | n/a | 1 | Jan 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $52.31 | n/a | 1 | Dec 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $1.15 | n/a | 1 | Jun 30, 2017 |
Edgewise Therapeutics
Sep 23, 2026
Reiterated: Buy
Price Target: $52 → $53
Current: $41.40
Upside: +28.02%
Maze Therapeutics
Sep 23, 2026
Reiterated: Buy
Price Target: $48
Current: $26.43
Upside: +81.61%
Travere Therapeutics
Sep 22, 2026
Reiterated: Buy
Price Target: $75 → $76
Current: $56.93
Upside: +33.50%
Ultragenyx Pharmaceutical
Sep 18, 2026
Reiterated: Hold
Price Target: $23
Current: $15.22
Upside: +51.12%
Xenon Pharmaceuticals
Sep 18, 2026
Reiterated: Buy
Price Target: $63 → $55
Current: $38.02
Upside: +44.66%
Vera Therapeutics
Sep 16, 2026
Reiterated: Hold
Price Target: $34
Current: $30.42
Upside: +11.77%
Sionna Therapeutics
Sep 15, 2026
Reiterated: Hold
Price Target: $5 → $6
Current: $4.91
Upside: +22.20%
Pharvaris
Sep 9, 2026
Reiterated: Buy
Price Target: $42 → $50
Current: $31.19
Upside: +60.31%
Climb Bio
Aug 19, 2026
Reiterated: Buy
Price Target: $20
Current: $10.94
Upside: +82.82%
Ardelyx
Aug 18, 2026
Reiterated: Buy
Price Target: $19 → $9
Current: $3.34
Upside: +169.46%
Aug 14, 2026
Reiterated: Hold
Price Target: $80
Current: $10.71
Upside: +646.97%
Aug 14, 2026
Reiterated: Buy
Price Target: $7
Current: $2.38
Upside: +194.12%
Aug 11, 2026
Reiterated: Buy
Price Target: $47
Current: $14.12
Upside: +232.86%
Aug 6, 2026
Reiterated: Buy
Price Target: $21 → $20
Current: $8.17
Upside: +144.80%
Aug 6, 2026
Reiterated: Buy
Price Target: $43 → $41
Current: $19.40
Upside: +111.34%
Aug 5, 2026
Reiterated: Buy
Price Target: $105 → $122
Current: $88.21
Upside: +38.31%
Aug 5, 2026
Reiterated: Buy
Price Target: $12 → $11
Current: $2.96
Upside: +271.62%
Aug 3, 2026
Reiterated: Buy
Price Target: $185 → $194
Current: $143.18
Upside: +35.49%
Jul 31, 2026
Reiterated: Hold
Price Target: $201 → $215
Current: $219.88
Upside: -2.22%
Jul 13, 2026
Reiterated: Buy
Price Target: $23 → $26
Current: $20.00
Upside: +30.00%
Jun 2, 2026
Reiterated: Sell
Price Target: $166 → $162
Current: $295.51
Upside: -45.18%
May 18, 2026
Reiterated: Buy
Price Target: $17 → $16
Current: $6.85
Upside: +133.58%
May 14, 2026
Reiterated: Hold
Price Target: $21 → $24
Current: $24.80
Upside: -3.23%
May 13, 2026
Reiterated: Buy
Price Target: $5 → $4
Current: $2.28
Upside: +75.44%
May 8, 2026
Reiterated: Buy
Price Target: $38
Current: $25.62
Upside: +48.32%
May 7, 2026
Reiterated: Buy
Price Target: $40
Current: $15.25
Upside: +162.30%
Aug 7, 2024
Reiterated: Hold
Price Target: $8 → $7
Current: $2.45
Upside: n/a
Apr 11, 2024
Reiterated: Buy
Price Target: $13 → $11
Current: $17.11
Upside: n/a
Mar 20, 2024
Reiterated: Hold
Price Target: $5
Current: $12.34
Upside: n/a
Aug 12, 2022
Reiterated: Buy
Price Target: $22 → $5
Current: $4.63
Upside: n/a
Feb 11, 2022
Reiterated: Buy
Price Target: $23
Current: $4.13
Upside: n/a
Aug 11, 2020
Reiterated: Hold
Price Target: $3 → $45
Current: $0.8112
Upside: n/a
Jan 2, 2019
Downgraded: Hold
Price Target: n/a
Current: $57.18
Upside: n/a
Jan 2, 2019
Downgraded: Hold
Price Target: n/a
Current: $504.73
Upside: n/a
Sep 12, 2018
Downgraded: Hold
Price Target: n/a
Current: $7.96
Upside: n/a
Aug 13, 2018
Reiterated: Hold
Price Target: n/a
Current: $1.54
Upside: n/a
Aug 8, 2018
Reiterated: Hold
Price Target: n/a
Current: $735.20
Upside: n/a
Jan 18, 2018
Initiated Coverage: Buy
Price Target: $24
Current: $6.13
Upside: n/a
Jan 4, 2018
Reiterated: Hold
Price Target: n/a
Current: $0.1964
Upside: n/a
Dec 7, 2017
Reiterated: Buy
Price Target: n/a
Current: $52.31
Upside: n/a
Jun 30, 2017
Reiterated: Buy
Price Target: $30
Current: $1.15
Upside: n/a